Advanced search
Publication Cover
Drug Delivery Volume 28, 2021 - Issue 1
Submit an article Journal homepage
1,905
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Tumor-targeted Gd-doped mesoporous Fe3O4 nanoparticles for T1/T2 MR imaging guided synergistic cancer therapy

Shaohui Zhenga School of Medical Imaging, Xuzhou Medical University, Xuzhou, China;b Department of Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China;c Institute of Medical Imaging and Digital Medicine, Xuzhou Medical University, Xuzhou, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8585-9428View further author information
ORCID Icon,
Shang Jina School of Medical Imaging, Xuzhou Medical University, Xuzhou, China;b Department of Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China;c Institute of Medical Imaging and Digital Medicine, Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Min Jiaoa School of Medical Imaging, Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Wenjun Wanga School of Medical Imaging, Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Xiaoyu Zhoua School of Medical Imaging, Xuzhou Medical University, Xuzhou, China;b Department of Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China;c Institute of Medical Imaging and Digital Medicine, Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Jie Xua School of Medical Imaging, Xuzhou Medical University, Xuzhou, China;b Department of Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China;c Institute of Medical Imaging and Digital Medicine, Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Yong Wanga School of Medical Imaging, Xuzhou Medical University, Xuzhou, China;b Department of Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China;c Institute of Medical Imaging and Digital Medicine, Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Peipei Doua School of Medical Imaging, Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Zhen Jind College of Medical Engineering, Xinxiang Key Laboratory of Neurobiosensor, Xinxiang Medical University, Xinxiang, Henan , ChinaView further author information
,
Changyu Wua School of Medical Imaging, Xuzhou Medical University, Xuzhou, China;b Department of Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China;c Institute of Medical Imaging and Digital Medicine, Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Jingjing Lia School of Medical Imaging, Xuzhou Medical University, Xuzhou, China;b Department of Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China;c Institute of Medical Imaging and Digital Medicine, Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Xinting Gea School of Medical Imaging, Xuzhou Medical University, Xuzhou, China;e School of Information Science and Engineering, Shandong Normal University, Jinan, ChinaCorrespondence[email protected]
View further author information
&
Kai Xua School of Medical Imaging, Xuzhou Medical University, Xuzhou, China;b Department of Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China;c Institute of Medical Imaging and Digital Medicine, Xuzhou Medical University, Xuzhou, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 787-799 | Received 08 Feb 2021, Accepted 23 Mar 2021, Published online: 19 Apr 2021

References

  • Arranja AG, Pathak V, Lammers T, Shi Y. (2017). Tumor-targeted nanomedicines for cancer theranostics. Pharmacol Res 115:87–95.
  • Berges O, Dhermain F, Bidault F. (2010). Radiation therapy and medical imaging. Bull Cancer 97:225–31.
  • Boehm I, Heverhagen JT. (2018). Delayed reaction following gadolinium-based contrast agent application. Magn Reson Imaging 50:10–1.
  • Chen PJ, Hu SH, Hsiao CS, et al. (2011). Multifunctional magnetically removable nanogated lids of Fe3O4-capped mesoporous silica nanoparticles for intracellular controlled release and MR imaging. J Mater Chem 21:2535–43.
  • Cheng L, Yang K, Li Y, et al. (2011). Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual-targeted photothermal therapy. Angew Chem Int Ed Engl 50:7385–90.
  • Cheng L, Yang K, Li Y, et al. (2012). Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy. Biomaterials 33:2215–22.
  • Courant T, Roullin VG, Cadiou C, et al. (2012). Hydrogels incorporating GdDOTA: towards highly efficient dual T1/T2 MRI contrast agents. Angew Chem Int Ed Engl 51:9119–22.
  • Cuevas C, Shibata D. (2009). Medical imaging in the diagnosis and management of cancer pain. Curr Pain Headache Rep 13:261–70.
  • Czeyda-Pommersheim F, Martin DR, Costello JR, Kalb B. (2017). Contrast agents for MR imaging. Magn Reson Imaging Clin N Am 25:705–11.
  • Fan Z, Fu PP, Yu H, Ray PC. (2014). Theranostic nanomedicine for cancer detection and treatment. J Food Drug Anal 22:3–17.
  • Fernando R, Downs J, Maples D, Ranjan A. (2013). MRI-guided monitoring of thermal dose and targeted drug delivery for cancer therapy. Pharm Res 30:2709–17.
  • Gotwals P, Cameron S, Cipolletta D, et al. (2017). Prospects for combining targeted and conventional cancer therapy with immunotherapy. Nat Rev Cancer 17:286–301.
  • Guo S, Li D, Zhang L, et al. (2009). Monodisperse mesoporous superparamagnetic single-crystal magnetite nanoparticles for drug delivery. Biomaterials 30:1881–9.
  • Gupta A, de Campo L, Rehmanjan B, et al. (2015). Evaluation of Gd-DTPA-monophytanyl and phytantriol nanoassemblies as potential MRI contrast agents. Langmuir 31:1556–63.
  • Hou X, Tao Y, Pang Y, et al. (2018). Nanoparticle-based photothermal and photodynamic immunotherapy for tumor treatment. Int J Cancer 143:3050–60.
  • Huang X, Zhang W, Guan G, et al. (2017). Design and functionalization of the NIR-responsive photothermal semiconductor nanomaterials for cancer theranostics. Acc Chem Res 50:2529–38.
  • Kijima S, Sasaki T, Nagata K, et al. (2014). Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT. World J Gastroenterol 20:16964–75.
  • Lee YT, Tan YJ, Oon CE. (2018). Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol 834:188–96.
  • Li J, You J, Wu C, et al. (2018). T1-T2 molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents. Int J Nanomedicine 13:4607–25.
  • Liu L, Li X, Chen L, Zhang X. (2018). Nanoscale functional biomaterials for cancer theranostics. Curr Med Chem 25:2987–3000.
  • Liu Y, Bhattarai P, Dai Z, Chen X. (2019). Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev 48:2053–108.
  • Lu J, Feng F, Jin Z. (2013). Cancer diagnosis and treatment guidance: role of MRI and MRI probes in the era of molecular imaging. Curr Pharm Biotechnol 14:714–22.
  • Perez-Herrero E, Fernandez-Medarde A. (2015). Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm 93:52–79.
  • Phukan B, Mukherjee C, Goswami U, et al. (2018). A new bis(aquated) high relaxivity Mn(II) complex as an alternative to Gd(III)-based MRI contrast agent. Inorg Chem 57:2631–8.
  • Qin J, Liu Q, Zhang J, et al. (2015). Rationally separating the corona and membrane functions of polymer vesicles for enhanced T2 MRI and drug delivery. ACS Appl Mater Interfaces 7:14043–52.
  • Robinson JT, Welsher K, Tabakman SM, et al. (2010). High performance in vivo near-IR (>1μm) imaging and photothermal cancer therapy with carbon nanotubes. Nano Res 3:779–93.
  • Shen S, Wang S, Zheng R, et al. (2015). Magnetic nanoparticle clusters for photothermal therapy with near-infrared irradiation. Biomaterials 39:67–74.
  • Tempany CM, Jayender J, Kapur T, et al. (2015). Multimodal imaging for improved diagnosis and treatment of cancers. Cancer 121:817–27.
  • Torre LA, Siegel RL, Ward EM, Jemal A. (2016). Global cancer incidence and mortality rates and trends-an update. Cancer Epidemiol Biomarkers Prev 25:16–27.
  • Vanneman M, Dranoff G. (2012). Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer 12:237–51.
  • Yang H, Zhuang Y, Sun Y, et al. (2011). Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Biomaterials 32:4584–93.
  • You J, Zhang R, Zhang G, et al. (2012). Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: a platform for near-infrared light-triggered drug release. J Control Release 158:319–28.
  • Zhou Z, Bai R, Munasinghe J, et al. (2017). T1-T2 dual-modal magnetic resonance imaging: from molecular basis to contrast agents. ACS Nano 11:5227–32.
  • Zhou Z, Sun Y, Shen J, et al. (2014). Iron/iron oxide core/shell nanoparticles for magnetic targeting MRI and near-infrared photothermal therapy. Biomaterials 35:7470–8.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.